Phacilitate top 20 advanced therapy biotechs to watch in 2020 ebook

The Top 20 Advanced Therapy Biotechs to Watch in 2020

Who have you got your eye on?

 
​The pace of innovation across cell and gene therapy biotechs is gaining speed and it can be challenging to keep track of scientific developments, new technologies and who might be looking for their next big partnership.

Where is the innovation happening in our industry?

Whose pipelines are showing promise of an approved product in 2020?

More importantly, whose will succeed in the market?


Without innovation, infrastructure and investment, advanced therapies will not succeed as commercially viable products. The innovation of science, manufacturing processes, payment and reimbursement and talent development are all critical success factors.
 
Phacilitate top 20 advanced therapy biotechs to watch in 2020 ebook

Phacilitate's biennial 'Top 20 Advanced Therapy Biotechs to Watch' e-book is a collection of 20 of the most innovative and exciting biotechs to watch over the coming year, curated with input from industry nominations, the Phacilitate:Exchange editorial board and Phacilitate.

Of course, we're impartial so here's the list in alphabetical order...
 
  1. Arcellx
  2. BlueRock Therapeutics
  3. CARSgen Therapeutics
  4. Discgenics
  5. Falcon Therapeutics
  6. Freeline Therapeutics
  7. GammaDelta Therapeutics
  8. Gyroscope Therapeutics
  9. Iovance
  10. Locate Bio
  11. Magenta Therapeutics
  12. MeiraGTx Holdings plc
  13. Morphosys
  14. Nuvation Bio
  15. Quell Therapeutics
  16. Rocket Pharma
  17. Stemson Therapeutics
  18. Sutura Therapeutics
  19. Tmunity
  20. WindMIL Therapeutics

Take a look at the e-book to find out more.